Guardion Health Sciences 주식

Guardion Health Sciences AAQS 2024

Guardion Health Sciences AAQS

6

티커

GHSI

ISIN

US40145Q4010

WKN

A2QQR4

Guardion Health Sciences의 현재 AAQS는 6입니다.

높은 AAQS는 회사가 성공적으로 발전하고 있다는 긍정적인 지표로 여겨질 수 있습니다.

투자자들은 이 회사가 수익을 창출하는데 좋은 길 위에 있다고 생각할 수 있습니다.

다른 한편으로, Guardion Health Sciences 주식의 AAQS를 달성한 이익과 같은 업계의 다른 회사들과 비교하는 것이 중요합니다. 높은 AAQS는 반드시 긍정적인 미래를 보장하는 것은 아닙니다. 이를 통해서만 회사의 성과에 대한 전체적인 그림을 얻을 수 있습니다.

회사의 발전을 더 잘 파악하기 위해, 동일 업계의 다른 회사들과 비교하여 AAQS를 조사하는 것이 중요합니다. 일반적으로 투자자들은 이익, EBIT, 현금 흐름 등 다른 지표들과 함께 회사의 AAQS를 항상 고려하여 투자 결정을 내려야 합니다.

Guardion Health Sciences Aktienanalyse

Guardion Health Sciences는 무엇을 하나요?

Guardion Health Sciences Inc is a public company based in San Diego, California, specializing in healthcare services. The company was founded in 2009 as Lifetech Industries and changed its name to Guardion Health Sciences Inc in 2016. Guardion Health Sciences focuses on the development and commercialization of diagnostic and therapeutic products that affect the human body's visual system. The company offers a variety of products targeting the prevention and treatment of visual disorders. Key areas of business for Guardion Health Sciences include diagnostics to determine the cause of visual disorders, as well as the development of therapies for their treatment. Guardion Health Sciences collaborates with ophthalmologists and optometrists to continuously improve development. In diagnostics, Guardion Health Sciences has developed a patented technology portfolio to enable precise and reliable diagnoses. These include the MapcatSF™ and VioVision™ tests, both of which consider the influence of light and nutrition on the health of the human eye and vision. These tests allow for a thorough examination of the eyes to determine the cause of visual disorders. Another important focus is the development of natural therapy products for the treatment of visual disorders. One of the key products is Measure™, a dietary supplement specifically designed to compensate for the lack of essential nutrients crucial for eye health and vision. The included nutrients include lutein, zeaxanthin, and omega-3 fatty acids, which help support eye health and vision. Measure™ is recommended as part of comprehensive eye care to improve visual health. Another important product from Guardion Health Sciences is Lumega-Z®, a dietary supplement specifically developed and patented for the treatment of macular degeneration. Macular degeneration, the leading cause of blindness in older adults, affects the center of the visual field and can be a vision-restricting condition. Lumega-Z® contains essential antioxidants, vitamins C, E, and zinc, to support macula health and improve overall visual vitality. Guardion Health Sciences also provides education, workshops, and training to optometrists, ophthalmologists, and other professionals in the field to keep them updated on preventive measures and treatment options. Guardion Health Sciences' business model focuses on selling and marketing diagnostic and therapeutic products in the North American market and other countries where the products have obtained the necessary regulatory approvals. Currently, the company is expanding and working to enter new markets. Overall, Guardion Health Sciences has established itself as a leading provider of vision improvement products. The company is known for leveraging the latest technologies and developments to deliver precise diagnoses and effective therapies to support healthy vision. With a strong customer base and a continuously growing market share, the company is well-positioned to continue growing and driving innovation in the field. The main focus of Guardion Health Sciences is the development and commercialization of diagnostic and therapeutic products for the visual system. The company collaborates with eye doctors and optometrists to improve development. The company has patented diagnostic technologies that allow for precise and reliable diagnoses of visual disorders. Guardion Health Sciences also develops natural therapy products, such as Measure™ and Lumega-Z®, to treat visual disorders. The company offers education and training to professionals in the field. Guardion Health Sciences sells and markets its products in North America and other approved countries. The company is expanding and aiming to enter new markets. Guardion Health Sciences is a leading provider of vision improvement products, using innovative technologies to deliver effective diagnoses and therapies for healthy vision. Guardion Health Sciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Guardion Health Sciences 주식에 대한 자주 묻는 질문

주식 저축계획은 투자자가 장기적으로 자산을 쌓아가는 매력적인 방법을 제공합니다. 주요 장점 중 하나는 이른바 '비용 평균 효과'인데, 이는 정기적으로 일정 금액을 주식이나 주식 펀드에 투자함으로써 가격이 낮을 때 자동으로 더 많은 비율을, 가격이 높을 때는 적은 비율을 구매하게 되므로 시간이 지남에 따라 주식 당 평균 매입 가격을 낮출 수 있습니다. 또한 주식 저축계획은 소규모 투자자도 소액으로 비싼 주식에 접근할 수 있도록 해주며, 규칙적인 투자는 규율 있는 투자 전략을 촉진하고 충동적인 매수나 매도와 같은 감정적인 결정을 피하는 데 도움이 됩니다. 게다가 투자자는 주식의 잠재적인 가치 상승뿐만 아니라 배당금 분배로부터도 이익을 얻을 수 있으며, 이를 재투자함으로써 복리 효과를 증대시켜 투자 자본의 성장을 강화할 수 있습니다.

Andere Kennzahlen von Guardion Health Sciences

Guardion Health Sciences 매출 주식에 대한 우리의 주식 분석은 매출, 이익, P/E 비율, P/S 비율, EBIT, 배당금에 대한 정보를 포함하며, 또한 주식, 시가 총액, 부채, 자기자본 및 Guardion Health Sciences 매출의 채무와 같은 측면을 고려합니다. 이러한 주제에 대한 더 자세한 정보를 찾으시는 경우, 우리의 하위 페이지에서 자세한 분석을 제공합니다: